| Long-lasting analgesia via targeted in situ repression of NaV1.7 in mice AM Moreno, F Alemán, GF Catroli, M Hunt, M Hu, A Dailamy, A Pla, ... Science translational medicine 13 (584), eaay9056, 2021 | 94 | 2021 |
| Defining the teratoma as a model for multi-lineage human development D McDonald, Y Wu, A Dailamy, J Tat, U Parekh, D Zhao, M Hu, A Tipps, ... Cell 183 (5), 1402-1419. e18, 2020 | 48 | 2020 |
| Facile engineering of long‐term culturable ex vivo vascularized tissues using biologically derived matrices M Hu, A Dailamy, XY Lei, U Parekh, D McDonald, A Kumar, P Mali Advanced healthcare materials 7 (23), 1800845, 2018 | 30 | 2018 |
| Hydrogel platform for aqueous two-phase concentration of a target to enhance its detection DT Kamei, BM Wu, DY Pereira, CM Wu, MF Yee, JA Keefe, CC Pearce, ... US Patent 11,327,075, 2022 | 29 | 2022 |
| Programmatic introduction of parenchymal cell types into blood vessel organoids A Dailamy, U Parekh, D Katrekar, A Kumar, D McDonald, A Moreno, ... Stem cell reports 16 (10), 2432-2441, 2021 | 18 | 2021 |
| Cell maps for artificial intelligence: AI-ready maps of human cell architecture from disease-relevant cell lines T Clark, J Mohan, L Schaffer, K Obernier, S Al Manir, CP Churas, ... bioRxiv, 2024 | 8 | 2024 |
| Charting oncogenicity of genes and variants across lineages via multiplexed screens in teratomas U Parekh, D McDonald, A Dailamy, Y Wu, T Cordes, K Zhang, A Tipps, ... Iscience 24 (10), 2021 | 3 | 2021 |
| Robust genome and cell engineering via in vitro and in situ circularized RNAs M Tong, N Palmer, A Dailamy, A Kumar, H Khaliq, S Han, E Finburgh, ... Nature Biomedical Engineering, 1-18, 2024 | 2 | 2024 |
| Reprogramming Adeno-Associated Virus Tropism Via Displayed Peptides Tiling Receptor-Ligands A Portell, KM Ford, A Suhardjo, J Rainaldi, MN Bublik, M Sanghvi, ... bioRxiv, 2022.09. 26.509383, 2022 | 2 | 2022 |
| Extensive in vitro and in vivo protein translation via in situ circularized RNAs A Kumar, N Palmer, K Miyasaki, E Finburgh, Y Xiang, A Portell, A Dailamy, ... bioRxiv, 2022.02. 11.480072, 2022 | 1 | 2022 |
| Use of 3d-printed freestanding structures for ex vivo tissue P Mali, U Parekh, A Dailamy, X Lei, M Hu US Patent App. 17/056,724, 2021 | 1 | 2021 |
| Charting and probing the activity of ADARs in human development and cell-fate specification A Dailamy, W Lyu, S Nourreddine, M Tong, J Rainaldi, D McDonald, ... Nature Communications 15 (1), 9818, 2024 | | 2024 |
| A Perturbation Cell Atlas of Human Induced Pluripotent Stem Cells S Nourreddine, Y Doctor, A Dailamy, A Forget, YH Lee, B Chinn, H Khaliq, ... bioRxiv, 2024.11. 03.621734, 2024 | | 2024 |
| Engineered vascularized organoids P Mali, A Dailamy, U Parekh US Patent App. 18/074,402, 2023 | | 2023 |
| Engineering Multi-Lineage Vascularized Tissues from Human Pluripotent Stem Cells A Dailamy University of California, San Diego, 2023 | | 2023 |
| Long-Lasting Analgesia via Targeted In Situ Repression of Nav1. 7 A Moreno, F Aleman, G Catroli, M Hunt, M Hu, A Dailamy, A Pla, S Woller, ... MOLECULAR THERAPY 29 (4), 188-188, 2021 | | 2021 |
| Long-lasting analgesia via targeted in situ repression of Naự1. 7 in mice A Dailamy, A Pla, SA Woller, N Palmer, U Parekh, L Delay, ... | | 2021 |
| Novel method to engineer translantable human tissues K Zhang, Y Wu, A Dailamy, M Prashant, D Mcdonald, U Parekh, M Hu | | 2020 |
